Giant prolactinoma case with side effects due to cabergoline
Open Access
- 16 March 2020
- journal article
- Published by Heighten Science Publications Corporation in Archives of Case Reports
- Vol. 4 (1), 012-014
- https://doi.org/10.29328/journal.acr.1001031
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Giant prolactinomas: the therapeutic approachClinical Endocrinology, 2013
- Cabergoline Associated with First Episode ManiaPsychosomatics, 2012
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2011
- Management of Psychosis Associated With a Prolactinoma: Case Report and Review of the LiteraturePsychosomatics, 2010
- Cabergoline-induced psychotic exacerbation in schizophrenic patientsGeneral Hospital Psychiatry, 2008
- Advances in the Treatment of ProlactinomasEndocrine Reviews, 2006
- The Epidemiology of ProlactinomasPituitary, 2005
- Primary Medical Therapy of Micro- and Macroprolactinomas in Men*Journal of Clinical Endocrinology & Metabolism, 2000
- A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic AmenorrheaThe New England Journal of Medicine, 1994
- FACTORS IN THE OUTCOME OF TRANSSPHENOIDAL SURGERY FOR PROLACTINOMA AND NON‐FUNCTIONING PITUITARY TUMOUR, INCLUDING PREOPERATIVE BROMOCRIPTINE THERAPYClinical Endocrinology, 1987